The UPC’s SOCO and GREC research groups are developing a personalised medicine platform to improve the psychological treatment for psychosis (PERMEPSY). Based on predictive models, the tool will predict therapy effectiveness to tailor treatment. The prototype will undergo a year-long clinical trial with patients from around the world.
The Research and Development Lab (/rdlab) provides IT support for the PERMEPSY project.
More information available at:
https://www.upc.edu/en/press-room/news/a-predictive-tool-for-personalised-psychosis-treatment